{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:30:57Z","timestamp":1783686657910,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jaad.2004.08.046","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T07:33:59Z","timestamp":1107243239000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination"],"prefix":"10.1016","volume":"52","author":[{"given":"Kim A.","family":"Papp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Goertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carle","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.08.046_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2133.2001.04133.x","article-title":"First experience of topical SDZ ASM 981 in children with atopic dermatitis","volume":"144","author":"Harper","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.08.046_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1067\/mjd.2002.122187","article-title":"Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents","volume":"46","author":"Eichenfield","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.08.046_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1542\/peds.110.6.1133","article-title":"The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis","volume":"110","author":"Whalley","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2004.08.046_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1067\/mai.2002.126500","article-title":"Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug","volume":"110","author":"Kapp","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2004.08.046_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.110.1.e2","article-title":"Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children","volume":"110","author":"Wahn","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2004.08.046_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mpd.2003.65","article-title":"Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants","volume":"142","author":"Ho","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2004.08.046_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2133.1999.02974.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology","volume":"141","author":"Grassberger","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.08.046_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/sder.2001.29066","article-title":"Pimecrolimus (Elidel, SDZ ASM 981)\u2014preclinical pharmacologic profile and skin selectivity","volume":"20","author":"Stuetz","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2004.08.046_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00003495-200262050-00007","article-title":"Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis","volume":"62","author":"Wellington","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2004.08.046_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.1997.tb03788.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology","volume":"137","author":"Meingassner","year":"1997","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2004.08.046_bib11","first-page":"257","article-title":"Pimecrolimus is more cell-selective than corticosteroids: in vivo and in vitro data","volume":"16","author":"Kalthoff","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2004.08.046_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.2003.05559.x","article-title":"Pimecrolimus does not affect Langerhans cells in murine epidermis","volume":"149","author":"Meingassner","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.08.046_bib13","first-page":"55","article-title":"Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression","volume":"7","author":"Baxter","year":"1975","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2004.08.046_bib14","first-page":"49","article-title":"Corticosteroids and immunoglobulin synthesis","volume":"7","author":"Butler","year":"1975","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2004.08.046_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1979.03300010037025","article-title":"Influenza vaccination in patients with rheumatic diseases\u2014safety and efficacy","volume":"242","author":"Herron","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.08.046_bib16","first-page":"1643","article-title":"Systemic side effects of topical preparation in children","volume":"58","author":"Saurat","year":"1982","journal-title":"Sem Hop"},{"key":"10.1016\/j.jaad.2004.08.046_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1749-6632.2003.tb06047.x","article-title":"Dendritic cells: controllers of the immune system and new promise for immunotherapy","volume":"987","author":"Banchereau","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2004.08.046_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1074-7613(03)00182-1","article-title":"Dendritic cells in immunity and tolerance\u2014do they display opposite functions?","volume":"19","author":"Moser","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2004.08.046_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000051813","article-title":"Low systemic exposure after repeated topical application of pimecrolimus (Elidel, SDZ ASM 981) in patients with atopic dermatitis","volume":"204","author":"Van Leent","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.08.046_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2003.10.247","article-title":"Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a 2-year study","author":"Papp","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.08.046_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM197308022890502","article-title":"Immune status of children one to 4 years of age as determined by history and antibody measurement","volume":"289","author":"Gold","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.08.046_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004161","article-title":"The sero-epidemiology of diphtheria in Western Europe: ESEN project; European sero-epidemiology network","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2004.08.046_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0950268801005234","article-title":"The seroepidemiology of measles in Western Europe","volume":"126","author":"De Melker","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2004.08.046_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268899004574","article-title":"The seroepidemiology of rubella in Western Europe","volume":"125","author":"Pebody","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2004.08.046_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/biomet\/54.1-2.167","article-title":"Estimation of the probability of an event as a function of several independent variables","volume":"54","author":"Walker","year":"1967","journal-title":"Biometrika"},{"key":"10.1016\/j.jaad.2004.08.046_bib26","series-title":"Statistical methods in medical research. Section 12.5","author":"Armitage","year":"1971"},{"key":"10.1016\/j.jaad.2004.08.046_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2003.12.584","article-title":"Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy","volume":"113","author":"Hanania","year":"2004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204022327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204022327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:35:47Z","timestamp":1759268147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204022327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0190962204022327"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.08.046","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}